Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | BCHE | P06276 | 9/20 | 0.41 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.39 |
| ▸ | HTR1A | P08908 | 4/20 | 0.39 |
| ▸ | DRD3 | P35462 | 4/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.39 |
| ▸ | DRD1 | P21728 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4080952 | 0.83 | BCHE (0.40) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL7620961 | 0.82 | PTGS1 (0.43) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL2496191 | 0.80 | BCHE (0.38) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL5070736 | 0.79 | BCHE (0.37) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL5073280 | 0.75 | BCHE (0.40) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL6767771 | 0.70 | MAOA (0.58) | PTGS1PTGS2BCHENOX1LMNA | |
| SCHEMBL20345839 | 0.68 | PTGS1 (0.54) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL3043989 | 0.68 | TSHR (0.50) | PTGS1SLC6A2LMNACYP1A2ALDH1A1 | |
| SCHEMBL9759954 | 0.65 | PTGS1 (0.40) | PTGS1PTGS2BCHENOX1CYP2D6 | |
| SCHEMBL4080875 | 0.65 | MEN1 (0.52) | BCHENOX1CYP2D6SLC6A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576201-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2009-08-18 | — | — | US | disclosed |
| US-20080167465-A1 | Electrochromic compound | FITZMAURICE DONALD | 2008-07-10 | — | — | US | disclosed |
| US-7358358-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2008-04-15 | — | — | US | disclosed |
| US-7253940-B2 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND (IE) | 2007-08-07 | — | — | US | disclosed |
| US-20050128562-A1 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-20050128561-A1 | Electrochromic compound | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-6870657-B1 | Electrochromic device | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-03-22 | — | — | US | disclosed |
| EP-1500969-A1 | Compound and its use in electrochromic devices | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-01-26 | — | — | EP | disclosed |
| EP-1224505-A1 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001027690-A2 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2001-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167465-A1 | Electrochromic compound | KCNH2, PRDM9, H1-10 | PTGS1 3369/4885PTGS2 2658/4885BCHE 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.